Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
Studies of EN-1639A (naltrexone): a new narcotic antagonist.
Social cognition in pediatric-onset multiple sclerosis (MS).
Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica.
Is multiple sclerosis a proresolution deficiency disorder?
Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination.
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers.
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
High-dose cyclophosphamide in the treatment of multiple sclerosis.
T cell vaccination in multiple sclerosis: results of a preliminary study.
The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration.
Modelling and Prediction of 25-Hydroxyvitamin D Levels in Norwegian Relapsing-Remitting Multiple Sclerosis Patients.
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient.
The value of the multiple sclerosis specialist nurse with respect to prevention of unnecessary emergency admission.
Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis
FDA approves injectable drug to treat opioid-dependent patients
Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide.
Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis.
Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review.
Preventive healthcare use among males with multiple sclerosis.
Rehabilitation in transverse myelitis.
Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model.
IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.

Pages